GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » New Horizon Health Ltd (HKSE:06606) » Definitions » ROA %

New Horizon Health (HKSE:06606) ROA % : 7.97% (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is New Horizon Health ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. New Horizon Health's annualized Net Income for the quarter that ended in Jun. 2023 was HK$275 Mil. New Horizon Health's average Total Assets over the quarter that ended in Jun. 2023 was HK$3,448 Mil. Therefore, New Horizon Health's annualized ROA % for the quarter that ended in Jun. 2023 was 7.97%.

The historical rank and industry rank for New Horizon Health's ROA % or its related term are showing as below:

HKSE:06606' s ROA % Range Over the Past 10 Years
Min: -196.15   Med: -74.43   Max: 3.8
Current: 3.8

During the past 5 years, New Horizon Health's highest ROA % was 3.80%. The lowest was -196.15%. And the median was -74.43%.

HKSE:06606's ROA % is not ranked
in the Medical Devices & Instruments industry.
Industry Median: -1.91 vs HKSE:06606: 3.80

New Horizon Health ROA % Historical Data

The historical data trend for New Horizon Health's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

New Horizon Health ROA % Chart

New Horizon Health Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22
ROA %
-74.43 -24.91 -118.52 -196.15 -3.07

New Horizon Health Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
ROA % Get a 7-Day Free Trial Premium Member Only -349.85 -16.05 -5.45 -1.11 7.97

Competitive Comparison of New Horizon Health's ROA %

For the Medical Devices subindustry, New Horizon Health's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


New Horizon Health's ROA % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, New Horizon Health's ROA % distribution charts can be found below:

* The bar in red indicates where New Horizon Health's ROA % falls into.



New Horizon Health ROA % Calculation

New Horizon Health's annualized ROA % for the fiscal year that ended in Dec. 2022 is calculated as:

ROA %=Net Income (A: Dec. 2022 )/( (Total Assets (A: Dec. 2021 )+Total Assets (A: Dec. 2022 ))/ count )
=-88.486/( (2882.235+2875.346)/ 2 )
=-88.486/2878.7905
=-3.07 %

New Horizon Health's annualized ROA % for the quarter that ended in Jun. 2023 is calculated as:

ROA %=Net Income (Q: Jun. 2023 )/( (Total Assets (Q: Dec. 2022 )+Total Assets (Q: Jun. 2023 ))/ count )
=274.876/( (2875.346+4020.199)/ 2 )
=274.876/3447.7725
=7.97 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is two times the semi-annual (Jun. 2023) net income data. ROA % is displayed in the 30-year financial page.


New Horizon Health  (HKSE:06606) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Jun. 2023 )
=Net Income/Total Assets
=274.876/3447.7725
=(Net Income / Revenue)*(Revenue / Total Assets)
=(274.876 / 1799.652)*(1799.652 / 3447.7725)
=Net Margin %*Asset Turnover
=15.27 %*0.522
=7.97 %

Note: The Net Income data used here is two times the semi-annual (Jun. 2023) net income data. The Revenue data used here is two times the semi-annual (Jun. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


New Horizon Health ROA % Related Terms

Thank you for viewing the detailed overview of New Horizon Health's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


New Horizon Health (HKSE:06606) Business Description

Traded in Other Exchanges
Address
400 Jiang’er Road, 13th Floor, T1 Building, Binjiang District, Zhejiang, Hangzhou, CHN, 310052
New Horizon Health Ltd is engaged in early cancer screening and in-home testing in China. The company has an early detection and cancer screening-focused pipeline of five products and product candidates with an emphasis on colorectal cancer screening. The company focuses on cancer prevention and cure through screening and early detection. It generates maximum revenue from ColoClear and Pupu Tube products.
Executives
Invesco Advisers, Inc. 2102 Investment manager
Chen Yiyou 2201 Interest of corporation controlled by you
Trident Trust Company (hk) Limited 2301 Trustee
Bancasa Holding Limited 2201 Interest of corporation controlled by you
Mst Development Limited 2101 Beneficial owner
Yao Naxin 2305 Beneficiary of a trust
Janus Henderson Group Plc 2102 Investment manager
Jpmorgan Chase & Co. 2106 Person having a security interest in shares
Invesco Developing Markets Fund 2106 Person having a security interest in shares
Zhu Yeqing 2101 Beneficial owner
Qiming Venture Partners V, L.p.
Qiming Gp V, L.p.
Qiming Corporate Gp V, Ltd.
Bei Jing Jun Qi Jia Rui Qi Ye Guan Li You Xian Gong Si 2201 Interest of corporation controlled by you
Jun Lian Zi Ben Guan Li Gu Fen You Xian Gong Si 2201 Interest of corporation controlled by you

New Horizon Health (HKSE:06606) Headlines

No Headlines